2024-11-17 14:45:02
The Menarini Group Announces Commercial Agreement for Vabomere, Orbactiv and Minocin in 68 Countries
Health/ 2023-07-22
The Menarini Group Announces Commercial ...

FLORENCE,Italy,Oct. 11,2018-- Expands on existing commercial and co-development agreement fordelafloxacin

Frost & Sullivan Publishes Immediate Update Report on Kadimastem Ltd.: World's First successful transplant of embryonic stem cells in ALS patients
Health/ 2023-07-22
Frost & Sullivan Publishes Immediate...

Due to a higher probability of success in current clinical trials (results due in mid-2019),target price increased to NIS 1.12

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release